宏柏新材(605366.SH):擬投建年產3萬噸特種有機硅新材料項目和年產4萬噸硅基新材料綠色循環產業鏈項目
格隆匯 9 月 7日丨宏柏新材(605366.SH)公佈,根據戰略發展需求,公司擬投資建設年產3.0萬噸特種有機硅新材料項目和年產4.0萬噸硅基新材料綠色循環產業鏈項目。公司第一屆董事會第二十九次會議審議通過了《關於公司以自有資金投資建設項目的議案》,根據《上海證券交易所股票上市規則》等相關規定,此次交易不構成關聯交易和重大資產重組,此次投資尚需提交公司股東大會批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.